September 5, 2012 – As the maker of Pradaxa issued a report last month that use of the drug had reached record levels, a federal judge ruled that they will have to face the potential of thousands of injury and death lawsuits over internal bleeding side effects.
If you have been affected by internal bleeding or the loss of a loved one from Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible.
Pradaxa is a popular blood thinner prescribed to prevent strokes and blood clots in those with atrial fibrillation. On August 27, 2012, manufacturer Boehringer Ingelheim issued an announcement that the drug has now been prescribed for one million patient-years of combined time, and has been used in over 70 countries worldwide.
Last year, the FDA announced it was launching an investigation into the safety of Pradaxa after they received 3,781 reports of side effects and 542 deaths among users of the drug, which was higher than the amounts expected.
Due to the number of victims who ave filed a Pradaxa lawsuit, a central court was recently established in Illinois to handle the claims.
On July 25th, Judge David Herndon, who will oversee the litigation, issued an order denying attempts by Boehringer Ingelheim to dismiss Pradaxa bleeding lawsuits.
Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.
Contact us today to speak with a lawyer, or for more information on the research, warnings, side effects and legal options relating to the drug Pradaxa.